Numerous IL-15-enhancing approaches have been used to treat different cancers, including leukemias and lymphomas, exploiting the main function of the cytokine to potentiate Natural Killer (NK) and T-cell responses and unleash immune-mediated cancer eradication. This evidence concerns the gene IL15 and leukemia.